Genentech Must Pay $300M In Royalties Case: Court
The California Supreme Court ruled Thursday that biotech company Genentech must pay $300 million in compensatory damages to City of Hope National Medical Center in a dispute over royalties on insulin...To view the full article, register now.
Already a subscriber? Click here to view full article